Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Inflammatory Bowel Diseases: World Market Report 2009-2024

Visiongain
February 23, 2009
137 Pages - Pub ID: VSG2196289
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Related Reports

Title
Published
Price
Snapshots US Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and  |  more...
Search inside this report
11/12/2009       $600.00
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
By: Datamonitor
Introduction Courtesy of the patent cliff, the pharmaceutical industry is set for a dramatic slow down in revenue growth from 2011. Industry players are therefore looking to implement strategies which will cushion them against the  |  more...
11/12/2009       $7,600.00
Generic Pharmaceuticals Industry Report
By: Plimsoll Publishing Ltd.
The Global Generic Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth  |  more...
11/1/2009       $1,500.00
Gastrointestinal (GI) Endoscopy Devices Worldwide
By: MarketStrat, Inc.
The purpose of this report is to analyze and size the world market for GI Endoscopy Devices and accessories, discuss key players and identifies trends impacting the market for these products. Topics covered include product  |  more...
11/1/2009       $2,995.00
Asia Pacific Pharma Sector Analysis
By: RNCOS
The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region  |  more...
11/1/2009       $1,200.00
DiseaseINFOPACK: Clostridium difficile in China
By: VacZine Analytics
Clostridium difficile (C.diff) is a Gram-positive bacterium, which in vulnerable hospitalized patients can cause mild uncomplicated diarrhea to severe-complicated disease where patients experience fever, tachycardia and psuedomembranous colitis. While information and literature pertaining to C.diff  |  more...
11/1/2009       $4,895.00
Pharmaceuticals Industry Report
By: Plimsoll Publishing Ltd.
The Global Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial  |  more...
11/1/2009       $1,500.00
Antipsychotics Market Forecast
By: Datamonitor
Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is  |  more...
10/28/2009       $15,200.00
Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion
By: Datamonitor
Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is  |  more...
10/28/2009       $15,200.00
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
By: Datamonitor
Introduction Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest  |  more...
10/20/2009       $5,700.00
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 2